Literature DB >> 7056771

The effect of a thigh tourniquet on the incidence of deep venous thrombosis after operations on the fore part of the foot.

M A Simon, D P Mass, C K Zarins, N Bidani, C J Gudas, C E Metz.   

Abstract

We performed a prospective randomized clinical study to determine whether use of a thigh tourniquet influences the incidence of deep venous thrombosis. The lower limbs of patients who were scheduled for elective surgery on the fore part of the foot were randomized and assigned to one of three treatment categories: Group I, no tourniquet; Group II, exsanguination by an Esmarch bandage before tourniquet application; and Group III, exsanguination by elevation of the extremity prior to application of a tourniquet. The 117 limbs of seventy-one patients included in this study were evaluated preoperatively and twenty-four and seventy-two hours postoperatively with 125I-labeled fibrinogen, and preoperatively and seventy-two hours postoperatively with Doppler ultrasound studies and phleborheography. The findings in all of the Doppler ultrasound studies and all of the phleborheograms were normal. Two of the 125I-fibrinogen studies were positive, but subsequent contrast venography revealed that these were false-positive findings. We therefore concluded that the use of a thigh tourniquet does not increase the risk of deep venous thrombosis in patients who have had an operation on the fore part of the foot.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7056771

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  3 in total

1.  [Not Available].

Authors:  M R Sarkar; L Kinzl
Journal:  Oper Orthop Traumatol       Date:  1999-09       Impact factor: 1.154

2.  Surgery and the pill.

Authors:  P H Dyson
Journal:  Br Med J (Clin Res Ed)       Date:  1985-09-28

3.  Different strategies for pharmacological thromboprophylaxis for lower-limb immobilisation after injury: systematic review and economic evaluation.

Authors:  Abdullah Pandor; Daniel Horner; Sarah Davis; Steve Goodacre; John W Stevens; Mark Clowes; Beverley J Hunt; Tim Nokes; Jonathan Keenan; Kerstin de Wit
Journal:  Health Technol Assess       Date:  2019-12       Impact factor: 4.014

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.